Liquidia's shares and report

The US company Liquidia Corp. (NASDAQ: LQDA) today released its financial results for 2021.

As for the company's shares, the stock opened at US$6.26 in yesterday's trading and closed on the plus side (+4.05%) at US$6.42.

Also, the maximum value per share was US$6.52 and the minimum was US$6.05. Volume of the company was 433,516 and Avg. Volume is 549,475.

However, over the last five days, the company's shares have lost -10.71%. And the maximum value reached USD 7.48 and the minimum value was USD 5.84. It is worth noting that the company has a market capitalisation of $336.403 million.

Report from biotechnology and drugs company

The company has stated in its report that it had cash of 57.5 million USD for the full year 2021.

Also, revenues amounted to US$12.9 million for the year. Cost of revenue was US$3.0 million for the year.

Research and development expenses amounted to US$20.5 million for the year, a decrease of US$11.7 million compared to the previous year.

General and administrative expenses were US$23.1 million for the year, a decrease of US$4.3 million compared to the previous year.

The net loss for the year ended 31 December 2021 was US$34.6 million.

Liquidia Corp. is a biotechnology and drugs company that was founded in 2004. Also, Roger Jeffs is CEO of the company, Mike Kaseta is CFO at Liquidia Corp., Robert Lippe is COO at the company, Tushar Shan is Chief Medical Officer, Rusty Schundler is General Counsel of the company, Scott Moomaw is SVP, Commercial, and Jason Adair is SVP, Corporate Development and Strategy.